newsfilter
← Latest News
GlobeNewswire·

G1 Therapeutics to Participate in Two August Investor Conferences

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that it will participate in two August investor conferences. On